VC funding update: Which Boston startups made bank in September

05Oct

VC funding update: Which Boston startups made bank in September

Portfolio News

Boston’s startups and tech companies were busy in September, pulling in collective billions from VCs and other investors. Here’s who raised and what they pulled in: Watertown-based pharmaceutical company Windgap Medical Inc. raised more than $17M in equity. Read more >>

Share this post

Related Posts

20Oct

MIN 134 Women Founders 2020

WEBOS Week 2020 is a curated week of programming and events hosted by partners throughout the City of Boston, focused... read more
09Feb

Announcing BostInno’s 150 Tech Madness 2017 Finalists

Tech Madness is friendly competition to see who the community thinks will be the most valuable tech company in five... read more
17Sep

Expectant moms get wellness help from unexpected entrepeneur

Inside a West Greenwich warehouse sit thousands of pretty little boxes, waiting to be shipped to some long-overlooked consumers. “There's been... read more
07Mar

Pixability offers a new self-service video ad platform

The company says this is the first to enable integrated campaigns across Facebook, Instagram and YouTube. Read more >> read more
16Sep

Patient-Derived Organoids Transform Precision Medicine

Advances in cell culture techniques don’t just mean more accurate models, but more personal ones. For decades scientists have been... read more
09Jun

RevBio is Awarded a $2 Million Grant to Advance the Development of its Novel Dental Adhesive Bone Scaffold Product

RevBio, Inc., announced that it has been awarded a $2 million Phase II Small Business Innovation Research (SBIR) grant from... read more
15Jan

Odessa man’s vision changed by electronic glasses

Nick Flores, 23, received electronic glasses from eSight this past October to help enhance his vision. Read more >> read more
26Sep

Seattle gene therapy biotech startup Immusoft raises $4.5M

Seattle-based biotech startup Immusoft raised another $4.5 million and landed a $467,000 NIH grant to help further development of its... read more
18Oct

CytoAgents Announces Initiation of Patient Enrollment in Phase 1b/2a Clinical Trial to Treat Cytokine Release Syndrome in CAR T-cell Therapy

CytoAgents, Inc., a clinical-stage biotechnology company developing a safe, effective treatment for Cytokine Release Syndrome (CRS), today announced that it... read more
25Nov

Elizabeth Banks Shares Her Favorite Accessories, Kitchenware and More Go-to Holiday Gifts — All Under $100!

"It's a little burst of luxury in a can and serves as a perfect gift during holiday celebrations," says Banks,... read more